Acute Myelogenous Leukemia: Genetics, Biology And Therapy-..

Código: 1023542 Marca: Springer Publishing

R$ 456,42

até 4x de R$ 114,10 sem juros

ou R$ 433,60 via Pix

Qtde: Adicionar ao carrinho Disponibilidade: 45 dias úteis Estoque: 167 unidades

Parcelas
- 1x de R$ 456,42 sem juros
- 2x de R$ 228,21 sem juros
- 3x de R$ 152,14 sem juros
- 4x de R$ 114,10 sem juros
R$ 433,60
R$ 456,42

This volume contains a multitude of chapters from pioneers in the area of genetic mechanisms, targeted therapy, biology and mouse models for acute myelogenous leukemia. AML is the most common form of leukemia in adults. It is a deadly form of malignancy, the prognosis for which has not improved in the last two decades. More importantly, it is a malignancy that is seen in older adults, therefore the number of cases is likely to rise as the population ages. Over the past 15 years, genetic mechanisms underlying AML have begun to unfold. Additional research in this area has helped identify key components and characteristics. Consequently, targeted therapy of AML is receiving much attention. It is the hope of researchers that as with chronic myelogenous leukemia (CML), and the drug, Gleevec, a targeted therapy for AML will be discovered. This book adds much to the debate.

ISBN	9780387692579
Autor(a)	Nagarajan, Lalitha
Editora	Springer Publishing
Ano de edição	2009
Páginas	280
Acabamento	Capa Dura